On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Michael Davidson

ResearcherPublications, citations & collaboration network

Michael Davidson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Michael Davidson have?

ScholarIQindexed works

Michael Davidson has 318 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Michael Davidson have?

ScholarIQcitation count

Michael Davidson has 16,218 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Michael Davidson?

ScholarIQh-index

Michael Davidson has an h-index of 49 in OpenAlex.

What is the i10-index of Michael Davidson?

ScholarIQi10-index

Michael Davidson has an i10-index of 90 in OpenAlex.

What is the ORCID of Michael Davidson?

ScholarIQorcid

The ORCID for Michael Davidson is on the source record.

What is the OpenAlex record for Michael Davidson?

ScholarIQopenalex

The OpenAlex for Michael Davidson is on the source record.

What are the most-cited papers on Michael Davidson?

ScholarIQmost cited works
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Vassily Trubetskoy, Antonio F. Pardiñas, Ting Qi, Georgia Panagiotaropoulou, Swapnil Awasthi, Tim B. Bigdeli, Julien Bryois, Chia‐Yen Chen, Charlotte Dennison, Lynsey S. Hall, Max Lam, Kyoko Watanabe, Oleksandr Frei, Tian Ge, Janet Harwood, Frank Koopmans, Sigurður H. Magnússon, Alexander Richards, Julia Sidorenko, Yang Wu, Jian Zeng, Jakob Grove, Minsoo Kim, Zhiqiang Li, Georgios Voloudakis, Wen Zhang, Mark J. Adams, Ingrid Agartz, Elizabeth G. Atkinson, Esben Agerbo, Mariam Al Eissa, Margot Albus, Madeline Alexander, Behrooz Z. Alizadeh, Köksal Alptekın, Thomas D. Als, Farooq Amin, Volker Arolt, Manuel Arrojo, Lavinia Athanasiu, M.H. Azevedo, Silviu‐Alin Bacanu, Nicholas Bass, Martin Begemann, Richard A. Belliveau, Judit Bene, Beben Benyamin, Sarah E. Bergen, Giuseppe Blasi, Julio Bobes, Stefano Bonassi, Alice Braun, Rodrigo A. Bressan, Evelyn J. Bromet, Richard Bruggeman, P.F. Buckley, Randy L. Buckner, Jonas Bybjerg‐Grauholm, Wiepke Cahn, Murray J. Cairns, Monica E. Calkins, Vaughan J. Carr, David Castle, Stanley V. Catts, Kimberley D. Chambert, Raymond Chan, Boris Chaumette, Wei Cheng, Eric F.C. Cheung, Siow Ann Chong, David Cohen, Angèle Consoli, Quirino Cordeiro, Javier Costas, Charles Curtis, Michael Davidson, Kenneth L. Davis, Lieuwe de Haan, Franziska Degenhardt, Lynn E. DeLisi, Ditte Demontis, Faith Dickerson, Dimitris Dikeos, Timothy G. Dinan, Srdjan Djurovic, Jubao Duan, Giuseppe Ducci, Frank Dudbridge, Johan G. Eriksson, Lourdes Fañanás, Stephen V. Faraone, Alessia Fiorentino, Andreas J. Forstner, Josef Frank, Nelson B. Freimer, Menachem Fromer, Alessandra Frustaci, Ary Gadelha, Giulio Genovese, Elliot S. Gershon
Nature. 20222,835 CitationsOPEN ACCESS
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver Howes, Robert A. McCutcheon, Ofer Agid, Andrea de Bartolomeis, Nico J.M. van Beveren, Michael L. Birnbaum, Michael Bloomfield, Rodrigo A. Bressan, Robert W. Buchanan, William T. Carpenter, David Castle, Leslie Citrome, Zafiris J. Daskalakis, Michael Davidson, Richard Drake, Serdar Dursun, Bjørn H. Ebdrup, Hélio Elkis, Peter Falkai, W. Wolfgang Fleischacker, Ary Gadelha, Fiona Gaughran, Birte Glenthøj, Ariel Graff‐Guerrero, Jorge Hallak, William G. Honer, James L. Kennedy, Bruce J. Kinon, Stephen M. Lawrie, Jimmy Lee, F. Markus Leweke, James H. MacCabe, Carolyn McNabb, Herbert Y. Meltzer, Hans‐Jürgen Möller, Shinchiro Nakajima, Christos Pantelis, Tiago Reis Marques, Gary Remington, Susan L. Rossell, Bruce R. Russell, Cynthia Siu, Takefumi Suzuki, Iris E. Sommer, David Taylor, Neil Thomas, Alp Üçok, Daniel Umbricht, James Walters, John M. Kane, Christoph U. Correll
American Journal of Psychiatry. 20161,124 CitationsOPEN ACCESS
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Paul M. Ridker, Matt Devalaraja, Florian M.M. Baeres, Mads D.M. Engelmann, G. Kees Hovingh, Milana Ivkovic, Larry Lo, Douglas Kling, Pablo E. Pérgola, Dominic S. Raj, Peter Libby, Michael Davidson
The Lancet. 2021692 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account